1. Aune, S. E., Herr, D. J., Kutz, C. J., & Menick, D. R. (2015). Histone deacetylases exert class-specific roles in conditioning the brain and heart against acute ischemic injury. Frontiers Neurology, 6, 145.
2. Bellenguez, C., Bevan, S., Gschwendtner, A., & ISGC, WTCCC2. (2012). Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nature Genetics, 44(3), 328–333.
3. Borghi, S. M., Carvalho, T. T., Staurengo-Ferrari, L., Hohmann, M. S., Pinge-Filho, P., Casagrande, R., et al. (2013). Vitexin inhibits inflammatory pain in mice by targeting TRPV1, oxidative stress, and cytokines. Journal of Natural Products, 76(6), 1141–1149.
4. Chen, Y. C., Wu, J. S., Yang, S. T., Huang, C. Y., Chang, C., Sun, G. Y., & Lin, T. N. (2012a). Stroke, angiogenesis and phytochemicals. Frontiers in Bioscience (Schol Ed)., 4, 599–610.
5. Chen, Y. T., Zang, X. F., Pan, J., Zhu, X. L., Chen, F., Chen, Z. B., & Xu, Y. (2012b). Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection. Clinical and Experimental Pharmacology and Physiology, 39(9), 751–758.